Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX) in a research note issued to investors on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.

Athersys Stock Performance

Shares of ATHX opened at $0.00 on Monday. The stock has a 50 day moving average of $0.01 and a 200 day moving average of $0.02. The company has a market capitalization of $277,735.50, a price-to-earnings ratio of 0.00 and a beta of -0.90. Athersys has a 12 month low of $0.01 and a 12 month high of $1.99.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.